Clinuvel Pharmaceuticals Ltd CLVLF
$6.54 $0.12 (1.73%) 1D
Last Updated: Aug 05, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
CLVLF Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Clinuvel Pharmaceuticals Ltd is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Clinuvel Pharmaceuticals Ltd. Stock Analysis CLVLF
United States Health Care Small Cap Clinuvel Pharmaceuticals Ltd. operates as a biopharmaceutical company. The company is focused on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as healthcare solutions for specialized populations. Its lead therapy, SCENESSE (afamelanotide 16mg), is approved for commercial distribution in Europe, the United States of America, Israel, and Australia as the first systemic photoprotective drug for the prevention of phototoxicity (anaphylactoid reactions and burns) in adult patients with erythropoietic protoporphyria (EPP). The company has operations in Europe, Singapore, and the United States of America. The company develops and manufactures NEURACTHEL (adrenocorticotropic hormone) in different formulations, to target neurological, endocrinological, and degenerative disorders. Its pharmaceutical product, PRENUMBRA, has been developed, and its use is to be expanded in the clinic from stroke to Parkinson's.
Clinuvel Pharmaceuticals Ltd (CLVLF) Chart
Financial Metrics & Statements of Clinuvel Pharmaceuticals Ltd (CLVLF)
FAQ's for Clinuvel Pharmaceuticals Ltd (CLVLF)
- As of August 2026, Clinuvel Pharmaceuticals Ltd CLVLF is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Clinuvel Pharmaceuticals Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Clinuvel Pharmaceuticals Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Clinuvel Pharmaceuticals Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Clinuvel Pharmaceuticals Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Clinuvel Pharmaceuticals Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Clinuvel Pharmaceuticals Ltd (CLVLF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
